SWAV News and Press, ShockWave Medical Inc. From 04/05/24

2024-04-05 12:30:03 ET Johnson Rice analyst issues HOLD recommendation for SWAV on April 5, 2024 10:37AM ET. SWAV was trading at $325.7 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, 4 - Hold, ...

2024-04-05 12:00:03 ET William Plovanic from Johnson Rice issued a price target of $335.00 for SWAV on 2024-04-05 10:37:00. The adjusted price target was set to $335.00. At the time of the announcement, SWAV was trading at $325.48. The overall price target consensus is a...

2024-04-05 11:15:02 ET Piper Sandler analyst issues NEUTRAL recommendation for SWAV on April 5, 2024 10:18AM ET. The previous analyst recommendation was Overweight. SWAV was trading at $325.54 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-04-05 11:15:02 ET Needham analyst issues HOLD recommendation for SWAV on April 5, 2024 09:20AM ET. The previous analyst recommendation was Buy. SWAV was trading at $325.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...

2024-04-05 09:13:00 ET U.S. stock index futures on Friday have largely held onto marginal gains amid a volatile reaction to the latest nonfarm payrolls report. Here are some stocks to watch on Friday: ... Read the full article on Seeking Alpha For further details see: ...

2024-04-05 07:18:49 ET Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premium The all-cash agreement values each share of Shockwav...

2024-04-05 06:55:01 ET More on ShockWave Medical Why Shockwave Medical Stands Out In The Medical Device Sector Shockwave Medical Q4 Earnings Recap: Plenty Of Reasons To Stay Bullish Shockwave Medical: Opening Arteries, Delivering Returns J&J-Shockwave dea...

Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention ...

2024-04-04 20:30:02 ET Wolfe Research analyst issues PEER PERFORM recommendation for SWAV on April 4, 2024 07:11PM ET. SWAV was trading at $319.99 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy, ...

2024-03-29 09:00:00 ET Shares of Shockwave Medical (NASDAQ: SWAV) charged sharply higher this week, soaring as much as 18%, according to data supplied by S&P Global Market Intelligence . As of market close on Thursday, the stock was still up 15.9%. The springboard that s...